The German pharmaceutical-and-agricultural group stated that the deal goals to enhance its ophthalmology pipeline.
Source link
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
Related Posts
Suspect in arson Sam Altman home aimed to kill, warned extinction AI
OpenAI CEO Sam Altman attends an occasion to pitch AI for companies in Tokyo, Feb. 3, 2025. Kim Kyung-hoon |…
The Race to Keep Humans in Control of AI
Invoice Gates sees a turbulent AI transition forward. Rob Enderle considers the dangers of more and more autonomous methods and…
Ring founder says AI is helping Amazon-owned doorbell unit fight crime
Ring CEO Jamie Siminoff Courtesy of Ring | Brandon Pal-Solis In 2023, Jamie Siminoff referred to as up Amazon‘s former…